Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJLEN.L Regulatory News (JLEN)

  • There is currently no data for JLEN

Research from QuotedData

29 Mar 2022 12:28

RNS Number : 4192G
JLEN Environmental Assets Group Ltd
29 March 2022
 

JLEN Environmental Assets - Research from QuotedData

 

29th March 2022

 

It's all about renewables

 

The renewable energy sector has been particularly buoyant over the past 18 months, and JLEN Environmental Assets (JLEN) is well-positioned to benefit. Initiatives such as the United Nations Climate Change Conference (COP26), new regulations on climate related financial disclosure - TCFD - and the Russo-Ukrainian crisis, combined with rising inflation and power prices, have only heightened the attractions of renewable energy.

 

The managers have identified an exciting pipeline of potential new investments made up of a number of opportunities from electric vehicle charging infrastructure to biomass, an area which JLEN dipped its toe into last year with its acquisition of the Cramlington facility. A recent fundraise means JLEN's managers can get to work on this pipeline now, while the trust is also on track to achieve its dividend target for 2021/22 of 6.80p.

 

Full research:

 

https://quoteddata.com/research/jlen-environmental-assets-renewables-qd/

 

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on JLEN Environmental Assets Group Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors. 

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASEEFFUEESEED
Date   Source Headline
1st May 20197:00 amRNSNotice of Results
15th Mar 201910:37 amRNSUpdate research from QuotedData
13th Mar 20194:56 pmRNSJohn Laing Pension Trust - Result of Share Sale
8th Mar 20197:00 amRNSJohn Laing Pension Trust - Proposed Sale of Shares
7th Mar 20197:00 amRNSNet Asset Value and Dividend
19th Dec 20187:00 amRNSAcquisition
30th Nov 20184:19 pmRNSTotal Voting Rights
22nd Nov 20187:00 amRNSHalf-year Results, Dividend Declaration
9th Nov 20187:00 amRNSNotice of Results
24th Oct 20185:11 pmRNSDirector/PDMR Shareholding
24th Oct 20183:59 pmRNSHolding(s) in Company
24th Oct 20183:47 pmRNSHolding(s) in Company
19th Oct 201811:55 amRNSResult of Issue
13th Sep 201811:44 amRNSUpdate research from QuotedData
12th Sep 20187:00 amRNSProposed Placing, Offer for Subscription
3rd Sep 20185:59 pmRNSHolding(s) in Company
23rd Aug 20181:04 pmRNSHolding(s) in Company
16th Aug 20187:01 amRNSNet Asset Value and Dividend Declaration
16th Aug 20187:00 amRNSAcquisition
15th Aug 20183:58 pmRNSResult of AGM
9th Jul 20187:00 amRNSAcquisition
26th Jun 201811:56 amRNSNotice of AGM
22nd Jun 20182:59 pmRNSPublication of Suppl.Prospcts
22nd Jun 20188:15 amRNSAcquisition
14th Jun 20187:00 amRNSAnnual Financial Report
31st May 20187:00 amRNSNet Asset Value and Dividend Declaration
23rd May 20187:00 amRNSCapital Markets Event
13th Apr 20184:29 pmRNSDirector Declaration
29th Mar 20185:48 pmRNSTotal Voting Rights
14th Mar 20185:57 pmRNSHolding(s) in Company
7th Mar 20187:00 amRNSResult of Initial Placing
6th Mar 20181:32 pmRNSUpdate research from QuotedData
2nd Mar 201811:09 amRNSResult of EGM
23rd Feb 201812:11 pmRNSPublication of Prospectus
21st Feb 20188:18 amRNSProposed Initial Placing
12th Feb 20187:00 amRNSPublication of Circular & Notice of EGM
2nd Feb 20187:00 amRNSAcquisition
23rd Jan 20187:00 amRNSNet Asset Value and Dividend Declaration
12th Dec 20177:00 amRNSAcquisition
6th Dec 201711:50 amRNSHolding(s) in Company
22nd Nov 20177:00 amRNSHalf-year Results, Dividend Declaration
6th Nov 20177:00 amRNSInvestment Adviser
8th Sep 20177:55 amRNSInitiation research from QuotedData
29th Aug 20177:00 amRNSAcquisition
17th Aug 20177:00 amRNSNet Asset Value and Dividend
16th Aug 20171:11 pmRNSResults of AGM
31st Jul 20177:00 amRNSTotal Voting Rights
14th Jul 20179:52 amRNSHolding(s) in Company
13th Jul 20173:16 pmRNSHolding(s) in Company
12th Jul 201710:00 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.